genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Drug Discovery
First-In-Human Trial of Marburg Vaccine Shows Promising Results
Infectious Disease Diagnostics
Exploring Ways to Block Malaria Transmission
Infectious Diseases
Collective Measles Virus Mutations Linked to Fatal Encephalitis
Bioprocessing
Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility
Infectious Diseases
Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Blood Disorders
Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds
Artificial Intelligence
Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block
Antibodies
Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis
Bioprocessing
Cell and Gene Therapy Scale-Up Challenges
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Therapeutics
Antidiabetics
Antidiabetics
Anti-Ulcerants
Antibacterials
Antibiotics
Anticoagulants
Antidiabetics
Antifungals
Antivirals
Autoimmune Disease Drugs
Biologics
Biosimilars
Cardiovascular Drugs
Cellular Therapeutics
Combination Therapies
Dermatologic Drugs
Enzyme Replacement Therapy
Generics
Hormone Replacement Therapy
Immuno-oncology
Immunotherapies
Lipid Regulators
Mental Health Drugs
Oncologics
Orphan Drugs
Pain
Protein Therapeutics
Psychoactive Drugs
Radiopharmaceuticals
Respiratory Drugs
Traditional Chinese Medications
Vaccines
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Antidiabetics
Intervening in Beta Cell-Immune System Dialogue Could Prevent Diabetes, Study Suggests
Antidiabetics
T1D Patients Benefit from Blood Pressure Drug in Two-Year Study
Antidiabetics
miRNA Downregulation in Red Blood Cells Causes Vascular Damage in Type 2 Diabetes
Antidiabetics
Smart Insulin for Diabetes Therapy Could Protect against Hypoglycemia
Antidiabetics
Wiping Out Zombie Cells in Fat May Delay or Alleviate Diabetes
Antidiabetics
Triple-Acting Diabetes Drug Reverses Memory Loss in Alzheimer’s Disease Mouse Models
Antidiabetics
Mouse Model May Offer Novel Insights for Treating Obesity and Type...
Antidiabetics
Hitachi Chemical Agrees $75M Deal for Caladrius Cell Therapy Manufacturer, PCT
Antidiabetics
Findings Point to a Novel Approach to the Treatment of Diabetes
Antidiabetics
Sanofi Ends Afrezza Collaboration with MannKind
Antidiabetics
Hanmi, Janssen Launch Up-to-$915M+ Diabetes/Obesity Alliance
Antidiabetics
Sanofi, Lexicon Partner to Develop Phase III Diabetes Drug
Antidiabetics
Sanofi, Hanmi Ink Up-to-$4.2B Long-Acting Diabetes Drug Alliance
Antidiabetics
Faulty “Dimmer Switch” in Diabetes Can Be Repaired
Scroll Up
Login
Subscribe